Characteristics | I–II (%) | III–IV (%) | ||
---|---|---|---|---|
Age | ||||
 ≤ 65 | 0 | (0.0) | 2 | (33.3) |
 > 65 | 2 | (33.3) | 2 | (33.4) |
Type | ||||
 Adenocarcinoma | 2 | (33.3) | 4 | (66.7) |
Gender | ||||
 Male | 1 | (16.7) | 3 | (50.0) |
 Female | 1 | (16.7) | 1 | (16.6) |
T stage | ||||
 T1 | 1 | (16.7) | 0 | (0.0) |
 T2 | 0 | (0.0) | 0 | (0.0) |
 T3 | 0 | (0.0) | 2 | (33.3) |
 T4 | 1 | (16.7) | 2 | (33.3) |
N stage | ||||
 N0 | 2 | (33.3) | 0 | (0.0) |
 N1 | 0 | (0.0) | 2 | (33.3) |
 N2 | 0 | (0.0) | 2 | (33.4) |
M stage | ||||
 M0 | 2 | (33.3) | 2 | (33.3) |
 M1 | 0 | (0.0) | 2 | (33.4) |
Locations | ||||
 Ascending colon | 1 | (16.7) | 1 | (16.6) |
 Sigmoid colon | 1 | (16.7) | 3 | (50.0) |
 Appendix colon | 0 | (0.0) | 0 | (0.0) |
Therapy | ||||
 Yes | 0 | (0.0) | 0 | (0.0) |
 No | 2 | (33.3) | 4 | (66.7) |